Effectiveness and Tolerability of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients Switched From Intravenous Tocilizumab: Results From the Extension Period of the Musashi Study

被引：0
|
作者：
Ogata, Atsushi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1295
引用
收藏
页码：S555 / S555
页数：1
相关论文
共 50 条
  • [21] Safety and Tolerability of Subcutaneous Sarilumab Compared to Intravenous Tocilizumab in Patients with RA
    Emery, Paul
    Rondon, Juan
    Garg, Anju
    van Hoogstraten, Hubert
    Graham, Neil
    Liu, Ming
    Parrino, Janie
    Spindler, Alberto J.
    Liu, Nancy
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] SAFETY AND TOLERABILITY OF TOCILIZUMAB IN LONG-TERM EXTENSION STUDIES OF RHEUMATOID ARTHRITIS
    Nash, P.
    Taylor, A.
    Hall, S.
    Jones, G.
    Youssef, P.
    Genovese, M.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 17 - 17
  • [23] Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study
    Ogata, Atsushi
    Amano, Koichi
    Dobashi, Hiroaki
    Inoo, Masayuki
    Ishii, Tomonori
    Kasama, Tsuyoshi
    Kawai, Shinichi
    Kawakami, Atsushi
    Koike, Tatsuya
    Miyahara, Hisaaki
    Miyamoto, Toshiaki
    Munakata, Yasuhiko
    Murasawa, Akira
    Nishimoto, Norihiro
    Ogawa, Noriyoshi
    Ojima, Tomohiro
    Sano, Hajime
    Shi, Kenrin
    Shono, Eisuke
    Suematsu, Eiichi
    Takahashi, Hiroki
    Tanaka, Yoshiya
    Tsukamoto, Hiroshi
    Nomura, Akira
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 799 - 809
  • [24] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [25] TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RATES OF MALIGNANCY: RESULTS FROM LONG-TERM EXTENSION CLINICAL TRIALS
    van Vollenhoven, Ronald F.
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Porter-Brown, Benjamin
    Rowell, Lucy
    Napalkov, Pavel
    Smart, Devi
    RHEUMATOLOGY, 2014, 53 : 91 - 92
  • [26] Tocilizumab In Patients With Rheumatoid Arthritis and Rates Of Malignancy: Results From Long-Term Extension Clinical Trials
    van Vollenhoven, Ronald F.
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Porter-Brown, Benjamin
    Rowell, Lucy
    Napalkov, Pavel
    Smart, Devi
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1005 - S1005
  • [27] THE EFFICACY AND SAFETY OF SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT WEEK 97: RESULTS FROM THE SUMMACTA STUDY
    Burmester, Gerd
    Rubbert-Roth, Andrea
    Cantagrel, Alain
    Hall, Stephen
    Leszczynski, Piotr
    Feldman, Daniel
    Rangaraj, Madura J.
    Roane, Georgia
    Ludivico, Charles
    Mysler, Eduardo
    Bennett, Melanie J.
    Rowell, Lucy
    Bao, Min
    RHEUMATOLOGY, 2015, 54 : 71 - 72
  • [28] Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis
    Bastida, Carla
    Ruiz-Esquide, Virginia
    Pascal, Mariona
    de Vries Schultink, Aurelia H. M.
    Yague, Jordi
    Sanmarti, Raimon
    Huitema, Alwin D. R.
    Soy, Dolors
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (04) : 716 - 725
  • [29] Effectiveness and Tolerability of Benepali in Rheumatoid Arthritis Patients Switched from Enbrel
    Dyball, Sarah
    Hoskins, Victoria
    Christy-Kilner, Sharon
    Haque, Sahena
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] ANALYSIS OF PERIOPERATIVE CLINICAL FEATURES AND COMPLICATIONS AFTER ORTHOPAEDIC SURGERY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: RESULTS FROM THE MULTICENTRE TOPP (TOCILIZUMAB IN PERIOPERATIVE PERIOD) STUDY
    Momohara, S.
    Hashimoto, J.
    Suguro, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 382 - 383
12345